SCHEMBL8058734

SCHEMBL8058734

COC(=O)[C@@H](N)CCCC(C)NC(=O)OCc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.49
CTSL P07711 1/20 0.48
LTA4H P09960 2/20 0.48
ALDH1A1 P00352 2/20 0.48
TRPM8 Q7Z2W7 1/20 0.48
ALOX15 P16050 1/20 0.48
KYNU Q16719 1/20 0.47
CTSK P43235 2/20 0.47
SLC1A3 P43003 1/20 0.46
SLC1A1 P43005 1/20 0.46
ELANE P08246 1/20 0.46
CTRB1 P17538 2/20 0.46
CYP1A2 P05177 2/20 0.46
CYP3A4 P08684 2/20 0.46
CYP2C9 P11712 2/20 0.46
TSHR P16473 2/20 0.46
CYP2C19 P33261 2/20 0.46
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3625562 0.91 SLC1A3 (0.53) ATMCTSLCTSKSLC1A3SLC1A1
SCHEMBL8064258 0.88 SIRT2 (0.57) CTSLLTA4HALDH1A1TRPM8ALOX15
SCHEMBL1345896 0.85 LTA4H (0.55) CTSLLTA4HALDH1A1SLC1A3SLC1A1
SCHEMBL8082160 0.85 ATM (0.49) ATMCTSLALDH1A1TRPM8ALOX15
SCHEMBL30433180 0.84 ATM (0.53) ATMCTSLCTSKELANECTRB1
SCHEMBL6841177 0.84 ATM (0.53) ATMCTSLCTSKELANECTRB1
Hydrochloric Acid SCHEMBL1347691 0.84 LTA4H (0.54) CTSLLTA4HALDH1A1SLC1A3SLC1A1
SCHEMBL4740486 0.84 SIRT2 (0.56) CTSLALDH1A1TRPM8ALOX15KYNU
SCHEMBL24845373 0.83 CPB1 (0.54) ATMCTSKELANECTRB1
SCHEMBL31665304 0.83 CPB1 (0.54) ATMCTSKELANECTRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100093811-A1 HIV PROTEASE INHIBITORS MERCK SHARP & DOHME CORP. 2010-04-15 US disclosed
US-20100093811-A1 HIV PROTEASE INHIBITORS MERCK SHARP & DOHME CORP. 2010-04-15 US disclosed
WO-2009042093-A1 HIV PROTEASE INHIBITORS MERCK & CO., INC. (US) 2009-04-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100093811-A1 HIV PROTEASE INHIBITORS PRSS1, FURIN, SERPINB1 ATM 1760/4885CTSL 31/4885LTA4H 1027/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.